Cognition Therapeutics, Inc. (CGTX)
NASDAQ·Healthcare·Biotechnology
$0.74
-1.95%
Mkt Cap $66.62M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+303.1%
Consensus $3.00 vs current $0.74
NASDAQ·Healthcare·Biotechnology
$0.74
-1.95%
Mkt Cap $66.62M
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+303.1%
Consensus $3.00 vs current $0.74